These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34271033)

  • 1. Nitric oxide releasing nanofibrous Fmoc-dipeptide hydrogels for amelioration of renal ischemia/reperfusion injury.
    Najafi H; Abolmaali SS; Heidari R; Valizadeh H; Jafari M; Tamaddon AM; Azarpira N
    J Control Release; 2021 Sep; 337():1-13. PubMed ID: 34271033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrin receptor-binding nanofibrous peptide hydrogel for combined mesenchymal stem cell therapy and nitric oxide delivery in renal ischemia/reperfusion injury.
    Najafi H; Abolmaali SS; Heidari R; Valizadeh H; Tamaddon AM; Azarpira N
    Stem Cell Res Ther; 2022 Jul; 13(1):344. PubMed ID: 35883125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural, mechanical, and biological characterization of hierarchical nanofibrous Fmoc-phenylalanine-valine hydrogels for 3D culture of differentiated and mesenchymal stem cells.
    Najafi H; Tamaddon AM; Abolmaali S; Borandeh S; Azarpira N
    Soft Matter; 2021 Jan; 17(1):57-67. PubMed ID: 33001116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simvastatin-Releasing Nanofibrous Peptide Hydrogels for Accelerated Healing of Diabetic Wounds.
    Janipour Z; Najafi H; Abolmaali SS; Heidari R; Azarpira N; Özyılmaz ED; Tamaddon AM
    ACS Appl Bio Mater; 2023 Nov; 6(11):4620-4628. PubMed ID: 37904513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GW274150, a potent and highly selective inhibitor of iNOS, reduces experimental renal ischemia/reperfusion injury.
    Chatterjee PK; Patel NS; Sivarajah A; Kvale EO; Dugo L; Cuzzocrea S; Brown PA; Stewart KN; Mota-Filipe H; Britti D; Yaqoob MM; Thiemermann C
    Kidney Int; 2003 Mar; 63(3):853-65. PubMed ID: 12631066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of myocardial ischemia/reperfusion injury by superinduction of inducible nitric oxide synthase.
    Kanno S; Lee PC; Zhang Y; Ho C; Griffith BP; Shears LL; Billiar TR
    Circulation; 2000 Jun; 101(23):2742-8. PubMed ID: 10851213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kupffer cells protect liver from ischemia-reperfusion injury by an inducible nitric oxide synthase-dependent mechanism.
    Hsu CM; Wang JS; Liu CH; Chen LW
    Shock; 2002 Apr; 17(4):280-5. PubMed ID: 11954827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of inducible nitric oxide synthase reduces renal ischemia/reperfusion injury.
    Chatterjee PK; Patel NS; Kvale EO; Cuzzocrea S; Brown PA; Stewart KN; Mota-Filipe H; Thiemermann C
    Kidney Int; 2002 Mar; 61(3):862-71. PubMed ID: 11849439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Titanium dioxide nanoparticles embedded in assembled dipeptide hydrogels for microfluidic photodegradation.
    Li Y; Zheng T; Du Y; Zhao B; Patel HP; Boldt R; Auernhammer GK; Fery A; Li J; Thiele J
    J Colloid Interface Sci; 2024 Jan; 654(Pt A):405-412. PubMed ID: 37852026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoteichoic acid from Staphylococcus aureus reduces renal ischemia/reperfusion injury.
    Chatterjee PK; Zacharowski K; Cuzzocrea S; Brown PA; Stewart KN; Mota-Filipe H; Thiemermann C
    Kidney Int; 2002 Oct; 62(4):1249-63. PubMed ID: 12234295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial nitric oxide synthase plays a main role in producing nitric oxide in the superacute phase of hepatic ischemia prior to the upregulation of inducible nitric oxide synthase.
    Miyake T; Yokoyama Y; Kokuryo T; Mizutani T; Imamura A; Nagino M
    J Surg Res; 2013 Aug; 183(2):742-51. PubMed ID: 23485075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ozone oxidative preconditioning protects the rat kidney from reperfusion injury: the role of nitric oxide.
    Chen H; Xing B; Liu X; Zhan B; Zhou J; Zhu H; Chen Z
    J Surg Res; 2008 Oct; 149(2):287-95. PubMed ID: 18262565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for peroxynitrite formation in renal ischemia-reperfusion injury: studies with the inducible nitric oxide synthase inhibitor L-N(6)-(1-Iminoethyl)lysine.
    Walker LM; Walker PD; Imam SZ; Ali SF; Mayeux PR
    J Pharmacol Exp Ther; 2000 Oct; 295(1):417-22. PubMed ID: 10992009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained delivery of insulin-loaded block copolymers: Potential implications on renal ischemia/reperfusion injury in diabetes mellitus.
    Tong F; Tang X; Luo L; Li X; Xia W; Lu C; Liu D
    Biomed Pharmacother; 2017 Jul; 91():534-545. PubMed ID: 28482291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of nitric oxide synthase reduces renal ischemia/reperfusion injury.
    Mark LA; Robinson AV; Schulak JA
    J Surg Res; 2005 Dec; 129(2):236-41. PubMed ID: 16140334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remote ischemic preconditioning protects liver ischemia-reperfusion injury by regulating eNOS-NO pathway and liver microRNA expressions in fatty liver rats.
    Duan YF; An Y; Zhu F; Jiang Y
    Hepatobiliary Pancreat Dis Int; 2017 Aug; 16(4):387-394. PubMed ID: 28823369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of intraperitoneal hydrogen injection on nitric oxide synthase mRNA and malondialdehyde following limb ischemia-reperfusion in rabbits.
    Wang DJ; Tian H; Zhuang BX; Wu HJ
    Acta Orthop Traumatol Turc; 2015; 49(5):558-64. PubMed ID: 26422353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of ischemic preconditioning on the systemic and renal hemodynamic changes in renal ischemia reperfusion injury.
    Ge YZ; Wu R; Xin H; Liu H; Lu TZ; Zhao YC; Shen JW; Hu ZK; Yu P; Zhou LH; Xu LW; Xu Z; Wu JP; Li WC; Zhu JG; Jia RP
    Int J Clin Exp Pathol; 2015; 8(2):1128-40. PubMed ID: 25972999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of tirofiban on ischemia/reperfusion-induced renal injury in vivo and in vitro.
    Guan W; Wang Z; Liu Y; Han Y; Ren H; Eric Wang W; Yang J; Zhou L; Zeng C
    Eur J Pharmacol; 2015 Aug; 761():144-52. PubMed ID: 25981297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipopolysaccharide-induced cross-tolerance against renal ischemia-reperfusion injury is mediated by hypoxia-inducible factor-2α-regulated nitric oxide production.
    He K; Chen X; Han C; Xu L; Zhang J; Zhang M; Xia Q
    Kidney Int; 2014 Feb; 85(2):276-88. PubMed ID: 24025643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.